Join the Retinopathy group to help and get support from people like you.
Retinopathy News
Rural America Faces Growing Shortage of Eye Surgeons
WEDNESDAY, Jan. 22, 2025 – Rural areas are facing an increasing shortage of eye surgeons who can treat conditions like cataracts, glaucoma and detached retinas, a new study says. More than 17% of...
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
WEDNESDAY, Jan. 22, 2025 – Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications...
Ingredient in Hair Dye Led to Woman's Vision Loss
THURSDAY, Sept. 12, 2024 – An ingredient in the hair dye a French woman used caused her to develop a vision-robbing retinopathy, researchers report. When she switched to a dye without these...
Free Eye Disease Screening Program Engaging High-Risk Adults
TUESDAY, Aug. 27, 2024 – A novel free eye disease screening program is engaging adults at high risk for eye disease who are underusing eye care services, according to a study published online Aug....
Eylea (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA
ROP is a leading cause of childhood blindness worldwide Eylea now approved to treat five retinal conditions caused by ocular angiogenesis TARRYTOWN, N.Y., Feb. 08, 2023 (GLOBE NEWSWIRE) --...
FDA Approves Genentech’s Lucentis (ranibizumab) for all Forms of Diabetic Retinopathy
South San Francisco, CA – April 17, 2017 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved Lucentis® ...